Testing effectiveness (Phase 2)Study completedNCT00673114
What this trial is testing
Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies
Who this might be right for
Hematologic MalignancyMyelodysplastic Syndrome (MDS)Aplastic Anemia
Joanne Kurtzberg, MD 3